Stocks News

LAST PRICE
502.0000
TODAY'S CHANGE (%)
Trending Up1.1800 (0.2356%)

Bid / Lots
500.8800/ 4
Ask / Lots
503.0400/ 4
Open / Previous Close
502.4200 / 500.8200
Day Range
Low 501.8950
High 504.0000
52 Week Range
Low 372.5000
High 583.3900
Volume
85,318
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 2, 2024
- DJ IDEXX Labs Is Maintained at Overweight by Barclays, from 2:00PM ET on Thursday May 02, 2024 by Dow Jones
  2:00PM ET on Thursday May 02, 2024 by Dow Jones
  Companies Mentioned: IDXX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IDXX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 02, 2024 14:00 ET (18:00 GMT)
- Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675, from 10:31AM ET on Thursday May 02, 2024 by MT Newswires
  10:31AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  10:31 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research ...
- BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653, from 10:30AM ET on Thursday May 02, 2024 by MT Newswires
  10:30AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  10:30 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average rating of outperform and price targets ranging from $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic res...
- Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570, from 10:20AM ET on Thursday May 02, 2024 by MT Newswires
  10:20AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  10:20 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and price target range of $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research fr...
- Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655, from 9:46AM ET on Thursday May 02, 2024 by MT Newswires
  9:46AM ET on Thursday May 02, 2024 by MT Newswires
  Companies Mentioned: IDXX
  09:46 AM EDT, 05/02/2024 (MT Newswires) -- IDEXX Laboratories (IDXX) has an average outperform rating and price target range of $400 to $653, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research fr...

Yesterday
- Mettler-Toledo Q1 Tops Estimates; Full-Year Guidance Revised, from 16 hours ago by MT Newswires
  16 hours ago by MT Newswires
  Companies Mentioned: MTD
- -- Earnings Flash (MTD) METTLER-TOLEDO INTERNATIONAL Posts Q1 EPS $8.89, vs. Street Est of $7.65, from 17 hours ago by MT Newswires
  17 hours ago by MT Newswires
  Companies Mentioned: MTD
- -- Earnings Flash (MTD) METTLER-TOLEDO INTERNATIONAL Reports Q1 Revenue $925.95M, vs. Street Est of $880.2M, from 17 hours ago by MT Newswires
  17 hours ago by MT Newswires
  Companies Mentioned: MTD
- --Mettler-Toledo Guides For FY 2024 EPS of $39.90-$40.40, vs CIQ Analyst Consensus of $39.85/Share, from 17 hours ago by MT Newswires
  17 hours ago by MT Newswires
  Companies Mentioned: MTD
- --Mettler-Toledo Guides For Q2 EPS of $8.90-$9.05, vs CIQ Analyst Consensus of $9.36/Share, from 17 hours ago by MT Newswires
  17 hours ago by MT Newswires
  Companies Mentioned: MTD
- West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing, from 18 hours ago by MT Newswires
  18 hours ago by MT Newswires
  Companies Mentioned: WST
May 3, 2024
- Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142, from 11:17AM ET on Friday May 03, 2024 by MT Newswires
  11:17AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating, from 11:07AM ET on Friday May 03, 2024 by MT Newswires
  11:07AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating, from 9:53AM ET on Friday May 03, 2024 by MT Newswires
  9:53AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH
- Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132, from 9:41AM ET on Friday May 03, 2024 by MT Newswires
  9:41AM ET on Friday May 03, 2024 by MT Newswires
  Companies Mentioned: ZBH

IDEXX Laboratories Inc
NASDAQ:IDXXUnited States

Search Criteria

May 2, 2024

DJ IDEXX Labs Is Maintained at Overweight by Barclays, from 2:00PM ET on Thursday May 02, 2024 by Dow Jones

Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675, from 10:31AM ET on Thursday May 02, 2024 by MT Newswires

BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653, from 10:30AM ET on Thursday May 02, 2024 by MT Newswires

Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570, from 10:20AM ET on Thursday May 02, 2024 by MT Newswires

Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655, from 9:46AM ET on Thursday May 02, 2024 by MT Newswires

Peers Headlines

Yesterday

Mettler-Toledo Q1 Tops Estimates; Full-Year Guidance Revised, from 16 hours ago by MT Newswires

-- Earnings Flash (MTD) METTLER-TOLEDO INTERNATIONAL Posts Q1 EPS $8.89, vs. Street Est of $7.65, from 17 hours ago by MT Newswires

-- Earnings Flash (MTD) METTLER-TOLEDO INTERNATIONAL Reports Q1 Revenue $925.95M, vs. Street Est of $880.2M, from 17 hours ago by MT Newswires

--Mettler-Toledo Guides For FY 2024 EPS of $39.90-$40.40, vs CIQ Analyst Consensus of $39.85/Share, from 17 hours ago by MT Newswires

--Mettler-Toledo Guides For Q2 EPS of $8.90-$9.05, vs CIQ Analyst Consensus of $9.36/Share, from 17 hours ago by MT Newswires

West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing, from 18 hours ago by MT Newswires

May 3, 2024

Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142, from 11:17AM ET on Friday May 03, 2024 by MT Newswires

UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating, from 11:07AM ET on Friday May 03, 2024 by MT Newswires

Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating, from 9:53AM ET on Friday May 03, 2024 by MT Newswires

Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132, from 9:41AM ET on Friday May 03, 2024 by MT Newswires